Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.

ABSTRACT:

SUBMITTER: Parnes A 

PROVIDER: S-EPMC9293412 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature